Our findings are, therefore, highly impactful in establishing not only a new form of MYBPC1 myopathy, but of a myopathy encompassing several genes that likely originates from structurally disordered and dysregulated sarcomeres. This evidence concerns the gene MYBPC1 and myopathy.